QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 reshape-lifesciences-receives-notice-of-allowance-for-us-patent-application-titled-intragastric-volume-occupying-device-and-method-for-fabricating-same-for-treating-obesity

https://patentcenter.uspto.gov/applications/16865242/ifw/docs

 why-reshape-lifesciences-stock-is-moving-higher-wednesday

ReShape Lifesciences reported that it gained approval from the United States Patent and Trademark Office for its application en...

 amid-ozempics-miracle-weight-loss-craze-this-company-peaked-over-100-in-tuesday-pre-market-after-receiving-us-patent-for-obesity-treatment

The approval comes at a time when global demand for weight loss drugs like Ozempic and WeGovy is increasing.

 reshape-lifesciences-has-received-a-notice-of-allowance-for-its-us-patent-application-17572387-titled-intragastric-device-for-treating-obesity

https://patentcenter.uspto.gov/applications/17572387/ifw/docs 

 reshape-lifesciences-has-received-fda-510k-clearance-for-reshape-calibration-tubes-and-gastric-balloon-suction-catheter

https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K241039

 reshape-lifesciences-q1-2024-gaap-eps-009-beats-016-estimate-sales-1944m-miss-2104m-estimate

Reshape Lifesciences (NASDAQ:RSLS) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of ...

 reshape-lifesciences-tweets-will-glp1-medications-replace-weightloss-surgery-according-to-reshape-ceo-paul-hickey-via-investingcom-glp1s-are-a-very-attractive-tool-to-fight-obesity-however-our-reshape-lap-band-is-safe-and-less-invasive

https://twitter.com/ReShapeLifesci/status/1775577028710015364